BIEMANS, Barbara,GUBA, Wolfgang,JAESCHKE, Georg,LINDEMANN, Lothar,O,HARA, Fionn,RICCI, Antonio,RUEHER, Daniel,VIEIRA, Eric
申请号：
HUE16739442
公开号：
HUE045145T2
申请日:
2016.07.11
申请国别(地区):
HU
年份:
2019
代理人:
摘要：
The present invention relates to positive allosteric modulators (PAMs) of metabotropic glutamate receptor 4 (mGluR4) that may be used for the treatment of conditions such as Parkinson's disease, anxiety, emesis, obsessive compulsive disorder, autism, neuroprotection, cancer, depression and diabetes type 2.
